ABDALI, ANAHITA
ABDALI, ANAHITA
Dipartimento di Scienze Farmacologiche e Biomolecolari
In Vitro Angiogenesis Inhibition with Selective Compounds Targeting the Key Glycolytic Enzyme PFKFB3
2021 A. Abdali, D. Baci, I. Damiani, F. Belloni, C. De Dominicis, M.L. Gelmi, A. Corsini, S. Bellosta
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)
2020 B. Emini Veseli, P. Perrotta, P. Van Wielendaele, A.-. Lambeir, A. Abdali, S. Bellosta, G. Monaco, G. Bultynck, W. Martinet, G.R.Y. De Meyer
INHIBITION OF ANGIOGENESIS USING GLYCOLYSIS INHIBITORS: AN IN VITRO STUDY
2019 A. Abdali
Inhibition of the Key Glycolytic Enzyme PFKFB3 with Novel Compounds Suppresses Vessel Sprouting
2018 A. Abdali, A. Corsini, D. Baci, C. De Dominicis, M. Zanda, M.L. Gelmi, S. Bellosta
Angiogenesis inhibition with novel compounds targeting the key glycolytic enzyme PFKFB3
2018 A. Abdali, A. Corsini, D. Baci, C. De Dominicis, M. Zanda, M.L. Gelmi, S. Bellosta
Differentially Expressed Proteins in Pulmonary Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension
2018 S.B. Nukala, O. Tura, L. Regazzoni, C. Marinello, A. Abdali, G. Aldini, V.F. Smolders VF, S.I. Blanco, J. Barbera, M. Cascante, M. Carini
Novel MMP-inhibiting peptides for stabilizing atherosclerotic plaques
2017 A. Abdali, H. Macut, S. Pellegrino, C. de Dominicis, M. Zanda, M.L. Gelmi, S. Bellosta
Novel compounds targeting PFKFB3, the key glycolytic enzyme, as a way to inhibit angiogenesis
2017 S. Bellosta, A. Corsini, C. de Dominicis, M. Zanda, M.L. Gelmi, A. Abdali